FdaApplication
ANDA 211861
Identifiers
- fda_app_no: ANDA211861
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2020-03-11 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | 10MG | TABLET;ORAL |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | 5MG | TABLET;ORAL |
2 products